AXSM
Axsome Therapeutics·NASDAQ
--
--(--)
--
--(--)
6.25 / 10
Outperform
Analyst sentiment is bullish: one strong‑buy recommendation (100%) and a weighted rating of 4.62, though the stock price fell 1.19% today. Money‑flow metrics are strong (overall 0.508 inflow, positive trends across block, Small, Medium, Large) except extra‑large, supporting a positive short‑term bias.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-25
InstitutionGuggenheim
Times predicted3
Historical Win Rate33.3%
What is the analyst consensus for AXSM?
- AXSM holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.25/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
